InnovaPrep selected for the National Institutes of Health Commercialization Accelerator Program

October 30, 2016

InnovaPrep was selected for the National Institutes of Health Commercialization Accelerator Program (CAP), a program designed to help some of the agency’s most promising small life science and healthcare Phase II awardees develop commercial business and transition their SBIR/STTR-funded technologies into the marketplace. Applicants are selected via a competitive process for a limited number of slots in the program. The CAP provides selected participants with individualized assistance through individual mentoring and consulting sessions, training workshops, and access to domain experts. This is in regards to InnovaPrep's Phase II FDA award for the high-flow hollow fiber concentrating Pipette Tip development.